PolyPeptide appoints Chief Commercial Officer

PolyPeptide Group AG has announced the appointment of Stéphane Varray as Chief Commercial Officer, effective January 2025. Varray will also join the PolyPeptide Management Committee. This decision aligns with PolyPeptide's strategy to evolve its commercial capabilities as the peptide market grows, particularly due to GLP-1 therapies.

Stéphane Varray, a Swiss/French citizen, holds a PhD in Organic Chemistry from the University of Montpellier. He previously worked at Corden Pharma, overseeing the peptides platform, and spent nearly two decades with Lonza in various commercial and leadership roles.

Juan José González, CEO of PolyPeptide, expressed his excitement about Varray's appointment, citing his exceptional track record and leadership experience in the peptide industry. González believes Varray will be instrumental in strengthening PolyPeptide's commercial agenda as part of their growth strategy.